Overcoming the stratum corneum: The modulation of skin penetration - A review

被引:410
作者
Trommer, H. [1 ]
Neubert, R. H. H. [1 ]
机构
[1] Univ Halle Wittenberg, Sch Pharm, Inst Pharmaceut & Biopharmaceut, D-4010 Halle, Germany
关键词
skin penetration; stratum corneum; transdermal drug delivery; penetration enhancers; penetration retarders; sonophoresis; lontophoresis;
D O I
10.1159/000091978
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
It is preferred that topically administered drugs act either dermally or transdermally. For that reason they have to penetrate into the deeper skin layers or permeate the skin. The outermost layer of the human skin, the stratum corneum, is responsible for its barrier function. Most topically administered drugs do not have the ability to penetrate the stratum corneum. In these cases modulations of the skin penetration profiles of these drugs and skin barrier manipulations are necessary. A skin penetration enhancement can be achieved either chemically, physically or by use of appropriate formulations. Numerous chemical compounds have been evaluated for penetration-enhancing activity, and different modes of action have been identified for skin penetration enhancement. In addition to chemical methods, skin penetration of drugs can be improved by physical options such as iontophoresis and phonophoresis, as well as by combinations of both chemical and physical methods or by combinations of several physical methods. There are cases where skin penetration of the drug used in the formulation is not the aim of the topical administration. Penetration reducers can be used to prevent chemicals entering the systemic circulation. This article concentrates on the progress made mainly over the last decade by use of chemical penetration enhancers. The different action modes of these substances are explained, including the basic principles of the physical skin penetration enhancement techniques and examples for their application.
引用
收藏
页码:106 / 121
页数:16
相关论文
共 115 条
[51]  
Krishnaiah YSR, 2002, J PHARM PHARM SCI, V5, P123
[52]  
Lademann J, 2004, HAUTARZT, V55, P1117, DOI 10.1007/s00105-004-0841-1
[53]   Follicular penetration. An important pathway for topically applied substances [J].
Lademann, J ;
Otberg, N ;
Richter, H ;
Jacobi, U ;
Schaefer, H ;
Blume-Peytavi, U ;
Sterry, W .
HAUTARZT, 2003, 54 (04) :321-323
[54]   Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin [J].
Larrucea, E ;
Arellano, A ;
Santoyo, S ;
Ygartua, P .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 52 (02) :113-119
[55]   Combined effect of low-frequency ultrasound and iontophoresis: Applications for transdermal heparin delivery [J].
Le, L ;
Kost, J ;
Mitragotri, S .
PHARMACEUTICAL RESEARCH, 2000, 17 (09) :1151-1154
[56]   Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport [J].
Lee, PJ ;
Langer, R ;
Shastri, VP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (04) :912-917
[57]   IRRITANT CUTANEOUS REACTIONS TO N-METHYL-2-PYRROLIDONE (NMP) [J].
LEIRA, HL ;
TILTNES, A ;
SVENDSEN, K ;
VETLESEN, L .
CONTACT DERMATITIS, 1992, 27 (03) :148-150
[58]  
LIPPOLD BC, 1984, BIOPHARMAZIE EINE EI
[59]  
Liu DK, 1999, J APPL TOXICOL, V19, pS41
[60]   Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer [J].
Lopes, LB ;
Collett, JH ;
Bentley, MVLB .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 60 (01) :25-30